Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

PubMed (Weighted) Links for Nucleotide (Select 139424470)


BGLF4 kinase modulates the structure and transport preference of the nuclear pore complex to facilitate nuclear import of Epstein-Barr virus lytic proteins.

Chang CW, Lee CP, Su MT, Tsai CH, Chen MR.

J Virol. 2015 Feb;89(3):1703-18. doi: 10.1128/JVI.02880-14. Epub 2014 Nov 19.


The conserved disulfide bond within domain II of Epstein-Barr virus gH has divergent roles in membrane fusion with epithelial cells and B cells.

Möhl BS, Sathiyamoorthy K, Jardetzky TS, Longnecker R.

J Virol. 2014 Dec;88(23):13570-9. doi: 10.1128/JVI.02272-14. Epub 2014 Sep 17.


A locus encompassing the Epstein-Barr virus bglf4 kinase regulates expression of genes encoding viral structural proteins.

El-Guindy A, Lopez-Giraldez F, Delecluse HJ, McKenzie J, Miller G.

PLoS Pathog. 2014 Aug 28;10(8):e1004307. doi: 10.1371/journal.ppat.1004307. eCollection 2014 Aug.


Epstein-Barr virus late gene transcription depends on the assembly of a virus-specific preinitiation complex.

Aubry V, Mure F, Mariamé B, Deschamps T, Wyrwicz LS, Manet E, Gruffat H.

J Virol. 2014 Nov;88(21):12825-38. doi: 10.1128/JVI.02139-14. Epub 2014 Aug 27.


Epstein-Barr virus glycoprotein gB and gHgL can mediate fusion and entry in trans, and heat can act as a partial surrogate for gHgL and trigger a conformational change in gB.

Chesnokova LS, Ahuja MK, Hutt-Fletcher LM.

J Virol. 2014 Nov;88(21):12193-201. doi: 10.1128/JVI.01597-14. Epub 2014 Aug 20.


Epstein-Barr virus-encoded latent membrane protein 2A promotes the epithelial-mesenchymal transition in nasopharyngeal carcinoma via metastatic tumor antigen 1 and mechanistic target of rapamycin signaling induction.

Lin Z, Wan X, Jiang R, Deng L, Gao Y, Tang J, Yang Y, Zhao W, Yan X, Yao K, Sun B, Chen Y.

J Virol. 2014 Oct;88(20):11872-85. doi: 10.1128/JVI.01867-14. Epub 2014 Aug 6.


Epstein-Barr virus nuclear antigen 3A protein regulates CDKN2B transcription via interaction with MIZ-1.

Bazot Q, Deschamps T, Tafforeau L, Siouda M, Leblanc P, Harth-Hertle ML, Rabourdin-Combe C, Lotteau V, Kempkes B, Tommasino M, Gruffat H, Manet E.

Nucleic Acids Res. 2014 Sep;42(15):9700-16. doi: 10.1093/nar/gku697. Epub 2014 Aug 4.


Lentivirus-mediated RNAi knockdown of LMP2A inhibits the growth of nasopharyngeal carcinoma cell line C666-1 in vitro.

Ying X, Zhang R, Wang H, Teng Y.

Gene. 2014 May 25;542(1):77-82. doi: 10.1016/j.gene.2014.03.020. Epub 2014 Mar 12.


Association between LMP2/LMP7 genetic variability and the metastasis risk of ovarian cancer in Chinese women in Beijing.

Song L, Ma N, Han L, Yan H, Yan B, Yuan Z, Cao B.

Hum Immunol. 2014 Mar;75(3):239-44. doi: 10.1016/j.humimm.2013.12.006. Epub 2013 Dec 27.


Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins.

Bollard CM, Gottschalk S, Torrano V, Diouf O, Ku S, Hazrat Y, Carrum G, Ramos C, Fayad L, Shpall EJ, Pro B, Liu H, Wu MF, Lee D, Sheehan AM, Zu Y, Gee AP, Brenner MK, Heslop HE, Rooney CM.

J Clin Oncol. 2014 Mar 10;32(8):798-808. doi: 10.1200/JCO.2013.51.5304. Epub 2013 Dec 16.


Epigenetic deregulation of the LMP1/LMP2 locus of Epstein-Barr virus by mutation of a single CTCF-cohesin binding site.

Chen HS, Martin KA, Lu F, Lupey LN, Mueller JM, Lieberman PM, Tempera I.

J Virol. 2014 Feb;88(3):1703-13. doi: 10.1128/JVI.02209-13. Epub 2013 Nov 20.


Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma.

Fish K, Chen J, Longnecker R.

Blood. 2014 Jan 23;123(4):530-40. doi: 10.1182/blood-2013-07-517649. Epub 2013 Oct 30.


Epstein-Barr virus latent membrane protein 2 effects on epithelial acinus development reveal distinct requirements for the PY and YEEA motifs.

Fotheringham JA, Raab-Traub N.

J Virol. 2013 Dec;87(24):13803-15. doi: 10.1128/JVI.02203-13. Epub 2013 Oct 9.


Nuclear transport of Epstein-Barr virus DNA polymerase is dependent on the BMRF1 polymerase processivity factor and molecular chaperone Hsp90.

Kawashima D, Kanda T, Murata T, Saito S, Sugimoto A, Narita Y, Tsurumi T.

J Virol. 2013 Jun;87(11):6482-91. doi: 10.1128/JVI.03428-12. Epub 2013 Apr 3.


Cellular localization of BARF1 oncoprotein and its cell stimulating activity in human epithelial cell.

Sakka E, Zur Hausen A, Houali K, Liu H, Fiorini S, Ooka T.

Virus Res. 2013 Jun;174(1-2):8-17. doi: 10.1016/j.virusres.2013.01.016. Epub 2013 Feb 28.


An RS motif within the Epstein-Barr virus BLRF2 tegument protein is phosphorylated by SRPK2 and is important for viral replication.

Duarte M, Wang L, Calderwood MA, Adelmant G, Ohashi M, Roecklein-Canfield J, Marto JA, Hill DE, Deng H, Johannsen E.

PLoS One. 2013;8(1):e53512. doi: 10.1371/journal.pone.0053512. Epub 2013 Jan 9.


The large groove found in the gH/gL structure is an important functional domain for Epstein-Barr virus fusion.

Chen J, Jardetzky TS, Longnecker R.

J Virol. 2013 Apr;87(7):3620-7. doi: 10.1128/JVI.03245-12. Epub 2013 Jan 16.


EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail.

Griffin BD, Gram AM, Mulder A, Van Leeuwen D, Claas FH, Wang F, Ressing ME, Wiertz E.

J Immunol. 2013 Feb 15;190(4):1672-84. doi: 10.4049/jimmunol.1102462. Epub 2013 Jan 11.


An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection.

Ohashi M, Fogg MH, Orlova N, Quink C, Wang F.

PLoS Pathog. 2012 Dec;8(12):e1003095. doi: 10.1371/journal.ppat.1003095. Epub 2012 Dec 27.


A soluble form of Epstein-Barr virus gH/gL inhibits EBV-induced membrane fusion and does not function in fusion.

Rowe CL, Connolly SA, Chen J, Jardetzky TS, Longnecker R.

Virology. 2013 Feb 5;436(1):118-26. doi: 10.1016/j.virol.2012.10.039. Epub 2012 Nov 29.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk